NRX 194204
4204-202-2011
Phase 2 small_molecule completed
Quick answer
NRX 194204 for Castration Resistant Prostate Cancer is a Phase 2 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Castration Resistant Prostate Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed